Australia Over The Counter (OTC) Drugs Market Analysis

Australia Over The Counter (OTC) Drugs Market Analysis


$ 3999

Australia Over The Counter (OTC) Drugs Market is projected to grow from $2.043 Bn in 2022 to $3.954 Bn by 2030, registering a CAGR of 8.60% during the forecast period of 2022 - 2030. The introduction of new technologies, such as digital health platforms, can also drive the OTC drug market in Australia by making it easier for consumers to access and purchase these products. There are a number of key players in the over-the-counter (OTC) drug market in Australia like Johnson & Johnson, GlaxoSmithKline, and Procter & Gamble.

ID: IN10AUON028 CATEGORY: OTC & Nutraceuticals GEOGRAPHY: Australia AUTHOR: Shivam Zalke

Buy Now

Australia Over The Counter (OTC) Drugs Market Executive Summary

Australia Over The Counter (OTC) Drugs Market is projected to grow from $2.043 Bn in 2022 to $3.954 Bn by 2030, registering a CAGR of 8.60% during the forecast period of 2022 - 2030.

Australia is a wealthy and developed country with a strong and diversified economy. It is the world's 13th-largest economy and the sixth-largest in the Asia-Pacific region. The Australian economy is driven by a number of sectors, including mining, agriculture, manufacturing, and services. Australia is a wealthy and developed country with a strong and diversified economy. It is the world's 13th-largest economy and the sixth-largest in the Asia-Pacific region. The Australian economy is driven by several sectors, including mining, agriculture, manufacturing, and services. As of 2022, the gross domestic product (GDP) of Australia was approximately $1.725 Tn. Australia spent an anticipated $202.5 Bn on health-related products and services in 2019–2020 or $7,926 per person on average.

The over-the-counter (OTC) drug market in Australia is composed of a wide range of products that are available without a prescription. These products are used to treat a variety of common ailments and are sold in pharmacies, supermarkets, and other retail outlets. Some examples of OTC drugs that are commonly available in Australia include pain relievers, cold and flu remedies, allergy medications, and digestive aids. In 2021, the OTC healthcare market in Australia was estimated to be worth $4.5 billion. During the forecast period, the market is anticipated to expand at a CAGR of more than 2%. Traditional medicines dominated the OTC healthcare market in Australia in terms of value. The category for vitamins and minerals is anticipated to experience the fastest value growth between 2021 and 2026. The primary distribution channels for OTC healthcare goods in the nation are drug stores and pharmacies.

australia otc drugs market analysis

Market Dynamics

Market Growth Drivers

There are several factors that can drive the over-the-counter (OTC) drug market in Australia. Some of the key drivers of the OTC drug market in Australia include:

  1. Aging population: As the population of Australia ages, the demand for OTC drugs that treat age-related conditions, such as pain and arthritis, is likely to increase.
  2. Increased awareness of self-care: As more people become aware of the importance of self-care, the demand for OTC drugs that can help treat minor health conditions is likely to increase.
  3. Changes in healthcare policy: Changes in healthcare policy, such as the introduction of new regulations or policies related to the use of OTC drugs, can impact the market.
  4. Economic factors: Economic factors, such as the state of the economy and changes in consumer spending patterns, can also impact the OTC drug market in Australia.
  5. Technological advancements: The introduction of new technologies, such as digital health platforms, can also drive the OTC drug market in Australia by making it easier for consumers to access and purchase these products.

Competitive Landscape

Key Players

There are a number of key players in the over-the-counter (OTC) drug market in Australia. These include both local and international manufacturers and distributors. Some examples of major players in the OTC drug market in Australia include:

  • Johnson & Johnson: A global healthcare company that manufactures and distributes a wide range of OTC products, including pain relievers, cold and flu remedies, and allergy medications.
  • GlaxoSmithKline: A global pharmaceutical company that manufactures and distributes a variety of OTC products, including cold and flu remedies, allergy medications, and digestive aids.
  • Procter & Gamble: A global consumer goods company that manufactures and distributes a range of OTC products, including pain relievers, cold and flu remedies, and allergy medications.
  • Reckitt Benckiser: A global consumer goods company that manufactures and distributes a range of OTC products, including cold and flu remedies, allergy medications, and digestive aids.
  • Aspen Pharmacare: A global pharmaceutical company that manufactures and distributes a variety of OTC products, including pain relievers, cold and flu remedies, and allergy medications.

In addition to these major players, there are also many smaller manufacturers and distributors of OTC drugs in Australia.

Healthcare Policies and Regulatory Landscape

In Australia, the regulatory framework for over-the-counter (OTC) drugs is administered by the Therapeutic Goods Administration (TGA), which is an agency of the Australian Government Department of Health. The TGA is responsible for regulating the quality, safety, and effectiveness of therapeutic goods in Australia, including OTC drugs.

The TGA has a number of processes in place to ensure the safety and efficacy of OTC drugs in Australia. These include:

  1. Registration: OTC drugs must be registered with the TGA before they can be marketed and sold in Australia. This process involves submitting data on the safety, quality, and efficacy of the product, as well as a range of other information.
  2. Classification: OTC drugs in Australia are classified into different categories based on their level of risk to the consumer. The classification determines the regulatory requirements that apply to the product, as well as the information that must be included on the label.
  3. Advertising: The TGA regulates the advertising of OTC drugs in Australia to ensure that consumers are not misled about the safety or effectiveness of these products.
  4. Labeling: The TGA sets standards for the labeling of OTC drugs in Australia to ensure that consumers have the necessary information to use these products safely and effectively.

The TGA also works with other government agencies and stakeholders to monitor the safety and effectiveness of OTC drugs in the market, and to take action if any issues are identified.

1. Executive Summary
1.1 Product Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Government Regulation in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel and Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation

6. Methodology and Scope

OTC Market Segmentation

By Category (Revenue, USD Billion):

The key categories in the Australia OTC healthcare market are analgesics, cough & cold preparations, first aid kits, indigestion preparations, medicated skin products, plasters & bandages, topical OTC medicines, traditional medicines, vitamins & minerals, and other OTC healthcare products. In 2021, the traditional medicines category led the Australia healthcare sector in terms of per capita expenditure followed by vitamins & minerals, and analgesics.

  • Traditional Medicine
  • Vitamins & Minerals
  • Analgesics
  • Cough &Cold Preparations
  • Topical OTC Medicines

By Distribution Channel (Revenue, USD Billion):

The key distribution channels in the Australia OTC healthcare market are drug stores & pharmacies, hypermarkets & supermarkets, convenience stores, food & drinks specialists, and cash & carries & warehouse clubs. Drug stores & pharmacies were the leading distribution channel in the Australia OTC healthcare sector in 2021 followed by hypermarkets & supermarkets and convenience stores.

  • Drug Stores & Pharmacies
  • Hypermarkets &Supermarkets
  • Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 18 January 2023

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up